Here, we identified LNCAROD as a novel METTL3‐mediated lncRNA that enhanced radioresistance in ESCC cells and was post‐transcriptionally stabilised by YTHDC1. This evidence concerns the gene METTL3 and esophageal squamous cell carcinoma.